Diabetes & Endocrinology

How to Act Now for Medicare Coverage of Obesity Medications: Call for Public Comment

How to Act Now for Medicare Coverage of Obesity Medications: Call for Public Comment

Medicare obesity drug coverage could enhance health equity. Act now: submit comments to CMS by January 27th. Read more.
Addressing Kidney Donation with Black Patients: A Guide for Physicians

Addressing Kidney Donation with Black Patients: A Guide for Physicians

Discuss kidney donation early with Black patients to address disparities. Provide information, dispel myths, and encourage open communication. Read the full guide for strategies.
People of Color Less Likely to Use Obesity-Management Medications

People of Color Less Likely to Use Obesity-Management Medications

Study reveals racial disparities in obesity-medication use. Black, Asian, Hispanic patients face barriers. Explore solutions to improve access.
75 Percent of Patients Stop Taking These Semaglutide Drugs After Two Years

75 Percent of Patients Stop Taking These Weight Loss Drugs After Two Years

75% discontinue Ozempic/Wegovy after two years, highlighting adherence challenges. Impact: High costs, side effects, and access issues. Explore management strategies.

The Complex Relationship Between HbA1c Levels and Life Expectancy in Older Adults

Optimal HbA1c for older adults: Aim for 6.8%-7.7% to maximize life expectancy, avoid excessively low targets. Read the full analysis.
Eli Lilly Drug Zepbound Slashes Diabetes Risk in Obese Users

Eli Lilly Drug Zepbound Reduced Diabetes Risk in Obese Users

Zepbound reduces type 2 diabetes risk by 90% in obese prediabetic patients, showing potential as a preventive treatment.
Biden Wants Medicare and Medicaid Cover GLP-1s

Biden Wants Medicare and Medicaid Cover GLP-1s

Biden proposes Medicare/Medicaid cover expensive GLP-1 obesity drugs. Potential impact on 7.4 million patients. Awaiting new administration's approval.
Semaglutide Drugs Might Help Lower Diabetic Alzheimer's Risk

Semaglutide Drugs Might Help Lower Diabetic Alzheimer’s Risk

Semaglutide may lower Alzheimer's risk in diabetics, suggesting neuroprotective benefits. Explore potential shifts in dementia management.
The Link Between Body Roundness Index and Cardiovascular Disease Risk

The Link Between Body Roundness Index and Cardiovascular Disease Risk

Higher Body Roundness Index trajectory increases cardiovascular disease risk. Explore implications for Black patients' risk assessment. Read the full analysis.
Novo Nordisk Questioned Over Ozempic Prices

Novo Nordisk Questioned Over Ozempic Prices

Novo Nordisk's high Ozempic prices impact access for underserved populations. Discuss cost-reduction strategies with PBMs. Read more for implications.
How Ozempic and Mounjaro Help People With Type 1 Diabetes Too

How Ozempic and Mounjaro Help People With Type 1 Diabetes, Too

Ozempic and Mounjaro aid weight loss, improve blood sugar in type 1 diabetes, potentially reducing obesity-related complications. Read further insights.
FDA Expands Approval of This Device for Type 2 Diabetes

FDA Expands Approval of This Device for Type 2 Diabetes

FDA approves Omnipod 5 for Type 2 diabetes; automates insulin delivery, potentially reducing disease management burden for Black patients.
AI-Powered Search. Human-Created Content.

What is the most crucial step to reduce Black maternal mortality rates?

Based on: https://blackdoctor.pro/maternal-mortality-covid-black-women-disparities/

What is the most crucial step to reduce Black maternal mortality rates?

Expert Medical Insights, Straight to Your Inbox

Insights That Keep Black Healthcare Leaders at the Forefront

By subscribing, you consent to receive emails from BlackDoctor.pro You may unsubscribe at any time. Privacy Policy & Terms of Service.

Empowering Culturally-Sensitive Healthcare Professionals

BlackDoctor Pro is an online destination created specifically for Black doctors and culturally-sensitive healthcare professionals. Our platform delivers trusted, relevant, and timely medical content, including in-depth articles, the latest treatment updates, healthcare policy, and emerging clinical studies. We are committed to empowering HCPs with the knowledge, resources, and support needed to achieve exceptional health outcomes in black communities.
Copyright © 2026, BlackDoctor, Inc. All rights reserved.
BlackDoctor Pro is an online destination created specifically for Black doctors and other culturally-sensitive healthcare professionals. Our platform delivers trusted, relevant, and timely medical content, including in-depth articles, the latest treatment updates, healthcare policy, and emerging clinical studies.
AI-Powered Search. Human-Created Content.